First Trust Advisors’s ImmunityBio IBRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.45M | Buy |
+548,506
| New | +$1.45M | ﹤0.01% | 1950 |
|
|
2025
Q1 | – | Sell |
-167,200
| Closed | -$428K | – | 2575 |
|
|
2024
Q4 | $428K | Sell |
167,200
-589,609
| -78% | -$1.51M | ﹤0.01% | 2295 |
|
|
2024
Q3 | $2.82M | Sell |
756,809
-130,811
| -15% | -$487K | ﹤0.01% | 1616 |
|
|
2024
Q2 | $5.61M | Buy |
+887,620
| New | +$5.61M | 0.01% | 1216 |
|
|
2023
Q2 | – | Sell |
-155,497
| Closed | -$283K | – | 2392 |
|
|
2023
Q1 | $283K | Buy |
155,497
+97,090
| +166% | +$177K | ﹤0.01% | 2248 |
|
|
2022
Q4 | $296K | Sell |
58,407
-16,962
| -23% | -$86K | ﹤0.01% | 2315 |
|
|
2022
Q3 | $375K | Buy |
75,369
+14,897
| +25% | +$74.1K | ﹤0.01% | 2295 |
|
|
2022
Q2 | $225K | Buy |
+60,472
| New | +$225K | ﹤0.01% | 2364 |
|
|
2021
Q3 | – | Sell |
-250,096
| Closed | -$3.57M | – | 2568 |
|
|
2021
Q2 | $3.57M | Sell |
250,096
-60,824
| -20% | -$868K | ﹤0.01% | 1559 |
|
|
2021
Q1 | $7.38M | Buy |
310,920
+190,101
| +157% | +$4.51M | 0.01% | 1050 |
|
|
2020
Q4 | $1.61M | Buy |
+120,819
| New | +$1.61M | ﹤0.01% | 1690 |
|